hoe 33342 has been researched along with Angiogenesis, Pathologic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Wang, CC; Yang, YC | 1 |
| Chen, D; Chou, J; Falcon, BL; Hanahan, D; McDonald, DM; Pietras, K; Sennino, B | 1 |
| Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J | 1 |
| Burns, PN; Foster, FS; Goertz, DE; Kerbel, RS; Yu, JL | 1 |
| Chaplin, DJ; Hill, SA | 1 |
| Davis, PD; Hill, SA; Lewis, G; Naylor, MA; Thomson, P; Tozer, GM | 1 |
| Busch, TM; Evans, SM; Koch, CJ; Wileyto, EP | 1 |
| Griffiths, JR; Kostourou, V; Robinson, SP; Whitley, GS | 1 |
| Rojiani, AM; Siemann, DW | 1 |
| Li, L; Rise, L; Rojiani, AM; Siemann, DW | 1 |
| Aliño, SF; Alvarez, FJ; Hilario, E; Rodeño, E; Simón, J | 1 |
11 other study(ies) available for hoe 33342 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzimidazoles; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Combined Modality Therapy; Cyclams; Dose Fractionation, Radiation; ErbB Receptors; Gefitinib; Green Fluorescent Proteins; Heterocyclic Compounds; Luminescent Agents; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pericytes; Prostatic Neoplasms; Quinazolines; Receptors, CXCR4; Tumor Microenvironment | 2013 |
Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Benzamides; Benzimidazoles; Carcinoma, Lewis Lung; Cell Proliferation; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Synergism; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pericytes; Piperazines; Proto-Oncogene Proteins c-sis; Pyrimidines; Treatment Outcome | 2011 |
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow | 2002 |
High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Humans; Melanoma; Mice; Mice, Nude; Neovascularization, Pathologic; Organophosphorus Compounds; Staining and Labeling; Tumor Cells, Cultured; Ultrasonics; Ultrasonography; Xenograft Model Antitumor Assays | 2002 |
The development of combretastatin A4 phosphate as a vascular targeting agent.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzimidazoles; Dose-Response Relationship, Drug; Mice; Mice, Inbred CBA; Microscopy, Fluorescence; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Radiation-Protective Agents; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured | 2002 |
Enhancement of vascular targeting by inhibitors of nitric oxide synthase.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Enzyme Inhibitors; Fluorescent Dyes; Mice; Mice, Inbred CBA; Models, Chemical; Necrosis; Neovascularization, Pathologic; Nitric Oxide Synthase; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured | 2002 |
Quantitative spatial analysis of hypoxia and vascular perfusion in tumor sections.
Topics: Animals; Benzimidazoles; Cell Hypoxia; Fluorescent Dyes; Mice; Mice, Inbred C3H; Neoplasms, Radiation-Induced; Neovascularization, Pathologic | 2003 |
Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging.
Topics: Amidohydrolases; Animals; Benzimidazoles; Dextrans; Female; Ferrosoferric Oxide; Glioma; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Neovascularization, Pathologic; Oxides | 2003 |
The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Necrosis; Neoplasms; Neovascularization, Pathologic; Organophosphorus Compounds; Sarcoma; Transplantation, Heterologous | 2005 |
Activity of the vascular targeting agent combretastatin A-4 disodium phosphate in a xenograft model of AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Biomarkers, Tumor; Blood Vessels; Cell Division; Cells, Cultured; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Mice; Mice, Nude; Neovascularization, Pathologic; Sarcoma, Experimental; Sarcoma, Kaposi; Stilbenes | 2002 |
Differential uptake of systemic fluorochrome Hoechst 33342 in lung and liver metastasis of B16 melanoma.
Topics: Animals; Benzimidazoles; Liver Neoplasms; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic | 1992 |